For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
AEON Biopharma Inc (AMEX: AEON) closed the day trading at $1.4 up 27.27% from the previous closing price of $1.1. In other words, the price has increased by $27.27 from its previous closing price. On the day, 0.92 million shares were traded. AEON stock price reached its highest trading level at $1.4 during the session, while it also had its lowest trading level at $1.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on August 18, 2023, initiated with a Buy rating and assigned the stock a target price of $18.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 21 ’25 when FISCHER JOST bought 60,000 shares for $0.49 per share. The transaction valued at 29,250 led to the insider holds 266,785 shares of the business.
FISCHER JOST bought 60,000 shares of AEON for $30,360 on May 20 ’25. The Director now owns 206,785 shares after completing the transaction at $0.51 per share. On May 19 ’25, another insider, FISCHER JOST, who serves as the Director of the company, bought 50,000 shares for $0.50 each. As a result, the insider paid 24,940 and bolstered with 146,785 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AEON now has a Market Capitalization of 16301300 and an Enterprise Value of 24298300.
Stock Price History:
The Beta on a monthly basis for AEON is 0.70, which has changed by -0.9816562 over the last 52 weeks, in comparison to a change of 0.13033986 over the same period for the S&P500. Over the past 52 weeks, AEON has reached a high of $83.52, while it has fallen to a 52-week low of $0.38. The 50-Day Moving Average of the stock is 71.46%, while the 200-Day Moving Average is calculated to be -56.16%.
Shares Statistics:
Over the past 3-months, AEON traded about 152.61K shares per day on average, while over the past 10 days, AEON traded about 521190 shares per day. A total of 11.54M shares are outstanding, with a floating share count of 9.52M. Insiders hold about 21.76% of the company’s shares, while institutions hold 10.92% stake in the company. Shares short for AEON as of 1759190400 were 114239 with a Short Ratio of 0.75, compared to 1756425600 on 155882. Therefore, it implies a Short% of Shares Outstanding of 114239 and a Short% of Float of 0.98.
Earnings Estimates
The market rating for AEON Biopharma Inc (AEON) is a result of the insights provided by 1.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.32, with high estimates of -$0.32 and low estimates of -$0.32.
Analysts are recommending an EPS of between -$0.66 and -$0.66 for the fiscal current year, implying an average EPS of -$0.66.
